👉 HCBI9.212 is a term in the field of biotechnology, specifically focusing on the production and application of human cells for medical research and therapy. It involves the creation of genetically modified (Gm) or transgenic (tg) human cells to study, treat, and potentially cure various diseases or conditions. These cells are typically derived from embryonic stem cells and can be engineered to express genes that target specific therapeutic targets, such as cancer cells or immune system components.
